Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bridge Therapy with Oxymetazoline and Mometasone Furoate in Children with Persistent Allergic Rhinitis
NCT07593898Phase 4Completed
- Sponsor
- Dr. Behcet Uz Children's Hospital
- Start
- Jan 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Mucinex Full Force Nasal Spray in persistent allergic rhinitis (PAR) (2 arms), sponsored by Dr. Behcet Uz Children's Hospital. Primary endpoint: Total Nasal Symptom Score at 4 weeks. Started Jan 2025; status: completed.
02
Drugs
Mucinex Full Force Nasal Spray
03
Conditions
persistent allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT07593898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07593898.